British-Swedish pharmaceutical company AstraZeneca is expanding its presence in the US in a bid to boost sales in its largest market.

WASHINGTON, D.C. — AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the United States by 2030, it said on Monday, the latest big investment by a ...

The biopharmaceutical company AstraZeneca announced it will $50 billion into the United States, with plans to open several manufacturing facilities in several states.

AstraZeneca has announced a new clinical study titled ‘Exacerbations and Their Outcomes in Egyptian Patients (EXACOS EG Population),’ which aims to explore the burden of severe exacerbations ...

WASHINGTON - AstraZeneca plans to spend US$50 billion (S$64 billion) to expand manufacturing and research capabilities in the U nited S tates by 2030, it said on July 21, the latest big investment ...

AstraZeneca said the mammoth investment will create tens of thousands of jobs across the US, “powering growth and delivering next-generation medicines for patients in America and worldwide”.

AstraZeneca has unveiled plans to invest $50bn (£37bn) in the US by the end of the decade amid fears it could ditch the London stock market.

AstraZeneca has revealed plans to invest $50bn in the US by 2030 with the aim of reaching $80bn in total revenue by 2030, with 50 per cent generated in the US.

AstraZeneca pledges $50 bln investment in US as pharma tariffs loom Author Ambar Warrick Stock Markets Published 07/21/2025, 08:56 PM ...

STORY: AstraZeneca plans to invest $50 billion in the U.S. by 2030.The Anglo-Swedish drugs giant said Monday (July 21) that the money will fund a new factory in Virginia, and expand other ...

AstraZeneca has become the latest pharma firm to announce a multi-billion investment in the U.S. The Anglo-Swedish biotech firm has committed to spend $50 billion by 2030.

AstraZeneca said on Thursday its experimental therapy, gefurulimab, met the primary goal and all secondary endpoints in a late-stage study aimed at improving symptoms of a rare autoimmune ...